会议第一天 : 2012 年 12 月 24 日， 星期二
08:00 签到及早茶
8:30 药物创制和开发周大会主席致开幕词
Li Chen, President and CEO, Hua Medicine, China
08:40 主题演讲 : 武田制药的研发合作模式创新 - 贴近医患需求，积极推进靶向药物开发
Dr Mary Haak-Frendscho, President and Chief Scientific Officer, Takeda San Francisco, USA
09:10 全球主题演讲 : 通 过合作扩展创新网络
Joe McCracken, Global Head of Business Development, Roche
09:40 全球主题演讲：有效应对研发生产力挑战：整合外部研究
Dr Helmut Haning, Senior Vice President and Head Global Innovation Outsourcing, Bayer Healthcare Pharmaceuticals, Germany
10:10 全体小组讨论：中国是否做好准备，领导全球药品创新与发展？
主持嘉宾：
Carl Firth, Chief Executive Officer, Aslan Pharmaceuticals, Singapore
讨论嘉宾 :
Frank Shen, Vice President Global Data Management and Statistics, Global Pharmaceutical R&D, Abbott, USA
Ling Chen, Vice President of R&D China Operations, GlaxoSmithKline, China
Ming Wang, Executive Director and Head of Diabetes Research, Amgen, USA
Youling Wu, Chief Executive Officer, ZheJiang Teruisi, China
11:00 上午茶歇
** 药物创制和开发周联合会议时段结束 **
11:30 2012 年亚洲生物仿制药会议主席致开幕词
Richard DiCicco , Chairman, Harvest Moon Pharmaceuticals, USA
11:40 生物仿制药的商业可行性
Richard DiCicco , Chairman, Harvest Moon Pharmaceuticals, USA
12:10 小组讨论：突破常规思维 — 进军监管法规不健全或无成熟监管体系的新兴医药市场
主持嘉宾：
Dr Tong Zhang, Director, Pan Regional Lead, Emerging Market Business Development, Merck, USA
讨论嘉宾 :
Abdullah Baaj , CEO, Boston Oncology, USA
Imtiaz Razzaq , Head of Business Development, Getz Pharma, Pakistan
Dr Peter Qian, CEO, Reviva Biopharmaceutics, General Secretary, CBA, USA
Dr Villoo Patell, Founder, Chairperson & Managing Director, Avesthagen, India
12:50 联谊午宴
14:00 小组讨论：中国企业应如何把握生物仿制药浪潮 , 扬帆前行 ?
主持嘉宾：
Dr Joe Zhou, CEO, Genor Biopharma, China
讨论嘉宾 :
Song Jun , Business Development Manager, Strategy & Business Development, Pfizer, China
Youling Wu , CEO, ZheJiang Teruisi, China
Dr Yingfei Wei, CEO, Elixirin Corporation, USA
Shirley Zhao, General Manager, Genzyme, China
Dr Xiaodong Yang , CEO, Apexigen, USA
14:40 中国的生物仿制药监管环境
Shirley Zhao, General Manager, Genzyme, China
15:10 分析预测美国的生物仿制药开发监管障碍并探寻可行解决之道
Dr Duu-Gong Wu, Executive Director, PharmaNet/i3, USA
15:40 下午茶歇
16:10 监管专题 ：生物仿制药全球发展环境：监管新思维？
Suzette Kox , Senior Director Scientific Affairs, European Generic Medicines Association (EGA), Belgium
16:40 制定可行方案，将生物仿制药计划付诸实践时应注意的重要事项
Dr Ming Wang, Executive Director and Head of Diabetes Research, Amgen, USA
17:10 小组前瞻讨论 ：如何从化学仿制药的发展中吸取经验教训？生物仿制药行业如何才能避免重蹈覆辙，脱离成本血战的残酷命运？
主持嘉宾：
Alan Sheppard, Principal,Global Generics, Thought Leadership, IMS Health, UK
讨论嘉宾 :
Dr Kyu Don Kim, Vice President, Strategic Business Development, Samsung, South Korea
Dr Ming Wang, Executive Director and Head of Diabetes Research, Amgen, USA
Dr Duu-Gong Wu, Executive Director, PharmaNet/i3, USA
Tim Oldham, President, Asia Pacific, Hospira, Australia
Dr David Shen, Vice President, Global Head of Biologics Development, Teva, USA
17:50 大会主席致词，第一天议程结束，随后举行联谊酒会
|
